Over the next 18 months, the study will investigate whether the Untire App can help cancer patients and survivors reduce their cancer-related fatigue and improve their quality of life. Participants will be recruited in the USA, UK, Canada, Australia, Germany, Spain and The Netherlands.
Participants in the trial will be placed into one of the two test groups: the first group will receive immediate 6-months access to the Untire App, the second group will get access after a period of 12 weeks of the study. This will allow researchers to explore fluctuations in patients’ fatigue and to compare that with the fluctuations of fatigue in a group actively using the App. In order to measure participant response, participants will be asked to complete ongoing questionnaires throughout the study about their levels of fatigue, quality of life, and other fatigue-related aspects such as physical activity, sleep, mood, and mindfulness.